Genzyme Corporation - Strategic SWOT Analysis Review

  • ID: 2517100
  • SWOT Analysis
  • 42 pages
  • GlobalData
  • Genzyme Corporation
1 of 5

FEATURED COMPANIES

  • Amgen Inc.
  • Bellus Health Inc.
  • Biogen Idec Inc.
  • Bionature E.A. Ltd.
  • Cellphire, Inc.
  • Forward Pharma A/S
  • MORE
Genzyme Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - A summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.

Highlights

Genzyme Corporation (Genzyme) is a biotechnology company, which develops and applies technologies in the life sciences targeting rare and special unmet medical needs. The company’s products and services focuses on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, and immune disease. Genzyme also develops products for the treatment of cardiovascular diseases, neurodegenerative diseases and other areas. The company operates through two business units namely, Rare Diseases business unit and Multiple Sclerosis business unit. Genzyme has presence across several geographies like Asia-Pacific, Europe and the Americas. The company is a subsidiary of Sanofi. Genzyme is headquartered in Massachusetts, the US.

Genzyme Corporation Key Recent Developments

Feb 27, 2015: Genzyme Recognizes International Rare Disease Day with Global Education and Fund-Raising Events; Announces Founding Partnership of Give RARE

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Amgen Inc.
  • Bellus Health Inc.
  • Biogen Idec Inc.
  • Bionature E.A. Ltd.
  • Cellphire, Inc.
  • Forward Pharma A/S
  • MORE
List of Tables

List of Figures

Section 1 - About the Company

Genzyme Corporation - Key Facts

Genzyme Corporation - Key Employees

Genzyme Corporation - Key Employee Biographies

Genzyme Corporation - Major Products and Services

Genzyme Corporation - Pharmaceutical Pipeline Products Data

Genzyme Corporation, Pipeline Products by Therapy Area

Genzyme Corporation, Pipeline Products by Development Phase

Genzyme Corporation - History

Genzyme Corporation - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Genzyme Corporation - Key Manufacturing Facilities

Joint Venture

Section 2 - Company Analysis

Genzyme Corporation - Business Description

Genzyme Corporation - Corporate Strategy

Genzyme Corporation - SWOT Analysis

SWOT Analysis - Overview

Genzyme Corporation - Strengths

Strength - Global Reach

Strength - Synergy through Sanofi

Strength - Research and Development Activities

Genzyme Corporation - Weaknesses

Weakness - Patent Litigations

Genzyme Corporation - Opportunities

Opportunity - New Market Approvals and Launches

Opportunity - Promising Product Pipeline

Opportunity - Changing Demographics

Opportunity - Strategic Partnerships

Genzyme Corporation - Threats

Threat - Highly Competitive Industry

Threat - Lengthy Drug Approval Process

Threat - Emergence of Biogenerics / Biosimilars

Genzyme Corporation - Key Competitors

Section 3 - Company’s Lifesciences Financial Deals and Alliances

Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Genzyme Corporation, Recent Deals Summary

Section 4 - Company’s Recent Developments

Feb 27, 2015: Genzyme Recognizes International Rare Disease Day with Global Education and Fund-Raising Events; Announces Founding Partnership of Give RARE

Section 5 - Appendix

Methodology

About

Contact Us

Disclaimer

List of Tables

Genzyme Corporation, Key Facts

Genzyme Corporation, Key Employees

Genzyme Corporation, Key Employee Biographies

Genzyme Corporation, Major Products and Services

Genzyme Corporation, Number of Pipeline Products by Therapy Area

Genzyme Corporation, Number of Pipeline Products by Development Stage

Genzyme Corporation, Pipeline Products By Therapy Area and Development Phase

Genzyme Corporation, History

Genzyme Corporation, Other Locations

Genzyme Corporation, Subsidiaries

Genzyme Corporation, Key Manufacturing Facilities

Genzyme Corporation, Joint Venture

Genzyme Corporation, Key Competitors

Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Genzyme Corporation, Recent Deals Summary

List of Figures

Genzyme Corporation, Pipeline Products by Therapy Area

Genzyme Corporation, Pipeline Products by Development Phase

Genzyme Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Genzyme Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Recordati Rare Diseases Inc.
Bellus Health Inc.
Keryx Biopharmaceuticals, Inc.
Bionature E.A. Ltd.
Forward Pharma A/S
Receptos, Inc.
BioClonetics Immunotherapeutics, Inc.
Cellphire, Inc.
Genentech, Inc.
GlaxoSmithKline plc
Biogen Idec Inc.
Shire Plc
Amgen Inc.
Novartis Vaccines and Diagnostics, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll